Kurs & Likviditet
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2022-03-01 15:11:31
As a consequence of exercise of 300,000 warrants in Nykode Therapeutics AS, the
share capital of Nykode Therapeutics AS has increased by NOK 3,000.00 from NOK
2,896,194.09 to NOK 2,899,194.09. The number of outstanding shares in the
company has increased by 300,000 from 289,619,409 to 289,919,409, each with a
par value of NOK 0.01.
Primary insider Christian Åbyholm, member of the board of Nykode Therapeutics
AS, exercised a total of 100,000 warrants as announced on February 15, 2022. An
employee has exercised a total of 200,000 warrants with expiry date of December
31, 2023. The 200,000 shares have been subscribed for at a strike price of NOK
12.20 per share.